Divi's Laboratories peers

Companies like Divi's Laboratorieslatest year

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

DIVISLAB₹9,558.50

Divi's Laboratories Ltd.

· Pharma & Health
₹ CrorePeersLAURUSLABSCOHANCEGLANDTORNTPHARMZYDUSLIFEMAXHEALTHDRREDDYCIPLAMcap ₹2.53L Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
DIVISLAB
FY26
LAURUSLABS
FY26
COHANCE
FY26
GLAND
FY26
Peer
Average
Valuation — at last close
P/E98.80×132.48×101.50×◆ 48.90×94.29× +5%
P/B15.11×22.22×◆ 4.66×4.85×10.58× +43%
EV/EBITDA72.62×67.62×42.58×◆ 28.92×46.37× +57%
Market Cap₹2.53L Cr₹1.18L Cr₹18,214 Cr₹50,235 Cr₹62,080 Cr +308%
Growth
Revenue CAGR 3Y10.78%4.09%19.17%◆ 21.06%14.77% -27%
Revenue CAGR 5Y8.67%7.19%◆ 17.57%13.18%12.65% -31%
Net Income CAGR 3Y◆ 12.09%3.91%-28.53%9.57%-5.02% +341%
Revenue YoY (latest Q)27.80%◆ 33.44%-23.13%19.57%9.96% +179%
Net Income YoY (latest Q)65.50%◆ 124.27%-197.39%47.09%-8.68% +855%
Profitability
EBITDA Margin◆ 32.59%26.09%18.82%25.34%23.42% +39%
Net Income Margin◆ 24.32%13.07%6.62%15.98%11.89% +105%
Return on Common Equity16.19%◆ 18.19%6.39%10.53%11.70% +38%
Return on Capital Employed17.80%◆ 20.48%6.18%11.73%12.80% +39%
Return on Assets◆ 13.89%8.97%3.43%8.66%7.02% +98%
Credit & Quality
Total Debt/Equity◆ 0.00×0.44×0.04×0.02×0.17× -100%
Interest Coverage◆ 129.48×7.60×6.44×36.24×16.76× +673%
Scale — latest FY
Revenue / Total Income₹10,560 Cr₹6,813 Cr₹2,269 Cr₹6,431 Cr₹5,171 Cr +104%
Net Income₹2,568 Cr₹890 Cr₹150 Cr₹1,027 Cr₹689 Cr +273%
Total Assets₹20,033 Cr₹10,511 Cr₹5,730 Cr₹12,511 Cr₹9,584 Cr +109%
EPS₹96.75₹16.47₹4.69₹62.35₹27.84 +248%
Book Value per Share₹632.49₹98.18₹102.23₹628.67₹276.36 +129%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.